Lupin | Business Upturn

Latest Articles

Lupin shares in focus today as company sign license and supply agreement for Semaglutide across 23 countries

Stock Market · Jan 21, 2026

blank

Top stocks to watch today, December 19: IndiGo, HCL Technologies, Tata Power, Ramco Systems, Lupin and more

Stock Market · Dec 19, 2025

blank

Lupin signs exclusive licensing agreement with Neopharmed for Plasil in Philippines and Brazil

Corporates · Dec 18, 2025

blank

Lupin receives positive CHMP opinion for biosimilar ranibizumab Ranluspec in Europe

Corporates · Dec 17, 2025

blank

Lupin receives US FDA EIR with VAI classification for Nagpur injectable facility

Corporates · Dec 16, 2025

blank

Lupin gets SBTi Validation for emission reduction targets across all emission scopes

Corporates · Dec 16, 2025

blank

Lupin subsidiary forms long-term strategic alliance with PolyPeptide Group to strengthen global peptide supply chain

Corporates · Dec 12, 2025

blank

Lupin Season 4: Release details, cast news and plot details – Everything we know so far

OTT · Dec 6, 2025

blank

Lupin receives U.S. FDA tentative approval for generic Siponimod tablets

Corporates · Dec 5, 2025

blank

Lupin signs exclusive licensing agreement with Valorum Biologics for biosimilar Armlupeg in the US

Corporates · Dec 4, 2025

blank

Lupin gets U.S. FDA Approval for Biosimilar Armlupeg

Corporates · Dec 1, 2025

blank

Lupin’s Nagpur Unit-1 clears USFDA Pre-Approval inspection with zero observations

Corporates · Nov 15, 2025

blank

Lupin shares jump over 2% after Bioresearch Centre gets zero observations from US FDA

Stock Market · Nov 10, 2025

blank

Lupin’s Pune Bioresearch Centre clears US FDA inspection with zero observations

Corporates · Nov 8, 2025

blank

Lupin Season 4: Latest updates on release date, cast news and plot details

OTT · Nov 3, 2025

Showing 15 of 99 articles